Previous Article | Next Article ![]()
Infect. Immun., 05 1996, 1685-1693, Vol 64, No. 5
LL An, E Pamer and JL Whitton
We have previously shown that vaccines expressing virus-derived
cytotoxic-T-lymphocyte (CTL) epitopes as short minigenes can confer
effective protection against virus challenges, and here we extend these
studies to the bacterium Listeria monocytogenes. Host defense against this
important human pathogen appears largely T cell mediated, and a nonamer CTL
epitope from the listeriolysin O (LLO) protein has been identified in
BALB/c mice. We have synthesized this nonamer as a minigene, expressed it
in a recombinant vaccinia virus (VV-list), and used this to immunize mice.
Memory CTLs cultured from VV-list-immunized mice specifically lyse target
cells pulsed with a nonamer peptide identified at LLO amino acid residues
91 to 99. Four weeks postimmunization, mice were challenged with L.
monocytogenes. By day 6 following challenge with a sublethal dose of L.
monocytogenes, mice immunized with VV-list showed a approximately 2,000- to
6,000-fold reduction in bacteria CFU in the spleen and liver. At this time
point, with control mice, bacterial were readily detectable by Gram stain
of the liver but were undetectable in the VV-list-immunized animals.
Additionally, when a normally lethal dose of bacteria was given, death was
delayed in VV-list-immunized animals. This study has demonstrated that a
single immunization with a recombinant vaccinia virus bearing only nine
amino acids from a bacterial pathogen can induce specific CTLs able to
confer partial protection against bacterial challenge.
Copyright © 1996, American Society for Microbiology
A recombinant minigene vaccine containing a nonameric cytotoxic-T- lymphocyte epitope confers limited protection against Listeria monocytogenes infection
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037, USA.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|